Director of the National Human Genome Research Institute (NHGRI), Eric Green, MD, PhD, presented at the HudsonAlpha Research Seminar January 25. Green discussed how far we’ve come since the Human Genome Project and the impact that HudsonAlpha is having in the field of personalized medicine. “They’re very innovative here,” Green said. “Considering how they’re quite new
Executive Vice President for Genomic Medicine Howard Jacob, PhD sat down with the Biotech Nation podcast to discuss integrating whole genomes into medicine and how whole genome sequencing can help end the diagnostic odyssey for patients with rare diseases. Click here to listen to the podcast.
Results from a momentous 50,726-person genomics study were released on Thursday, with some interesting and actionable lessons that have many experts talking. Published as two papers in Science, the research stems from the DiscovEHR project, led by researchers at the Geisinger Health System in Pennsylvania and the Regeneron Genetics Center, an off-shoot of Regeneron Pharmaceuticals. Read
The 2017 Rare Disease video is now available! Rare Disease Day is held on the last day of February every year to raise awareness of rare diseases. February 28 marks the tenth international Rare Disease Day coordinated by EURORDIS. On and around this day hundreds of patient organizations from countries and regions all over the
HudsonAlpha and Smith Family Clinic genetic counselors attended the NORD Rare Disease Breakthrough Summit Oct. 17-18. The Rare Disease Report caught up with Meagan Cochran to discuss whole genome sequencing at the Clinic.
Howard Jacob, PhD spoke with genomics and precision medicine publication Clinical OMICS about how commonplace sequencing is making disease less rare. While the practical approach of empirical trial and error has produced strong therapeutic results for many maladies, rare diseases represent a particular challenge for investigators that has been seemingly insurmountable—until the recent dawn of
Listen to the Podcast below, or view a Transcript of the Podcast here Combining Whole Genome Sequencing with Clinical Care with David Bick, M.D., CMO & Faculty Investigator, HudsonAlpha Institute for Biotechnology; Founder & CMO, Envision Genomics; Medical Director, Smith Family Clinic for Genomic Medicine. David Bick of HudsonAlpha speaks to CHI on July 20th, 2016. Dr.
Misconceptions impede progress in the integration of emerging genomic sciences into public health programs. Read more here about what the CDC has to say regarding genomics: http://blogs.cdc.gov/genomics/2016/07/13/five-misconceptions/
As whole-exome sequencing (WES) and whole-genome sequencing (WGS) move into routine clinical practice, it is timely to review data that might inform the debate regarding secondary findings (SF) and the development of policies that maximize participant benefit. Read the full article here: http://www.nature.com/gim/journal/vaop/ncurrent/full/gim2016109a.html